FDA Inspection
Richard L. Wasserman, M.D.Richard L. Wasserman, M.D. – FDA Inspection, Feb 2, 2012
Record Details
This FDA Inspection record concerns Richard L. Wasserman, M.D., with an inspection on February 2, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Richard L. Wasserman, M.D.
- Inspection Date
- February 2, 2012
- Product Type
- Biologics
View Company Profile
ID · 292729fb-bf28-43d1-9d9d-739466e9b18a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 766503
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(b)Case history records- inadequate or inadequate
- 21 CFR 312.66Unanticipated problems
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Richard L. Wasserman, M.D.
2| Date | Classification | Office | Project area |
|---|---|---|---|
| August 17, 2012 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
| February 5, 2010 | VAI | Center for Biologics Evaluation and Research | Bioresearch Monitoring |
Other documents for Richard L. Wasserman, M.D.
- FDA Inspection 797335 - 2012-08-17
- FDA Inspection 645390 - 2010-02-05
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.